Array Biopharma Issues Slideshow Presentation Related to Q3 Earnings: Raises FY15 Loss Outlook from $0.06/Share to $0.01/Share vs Loss of $0.07/Share Est., Sales $50M, Up from Previously-Issued $45M, vs $45M Est.